PREGNANT WOMAN, FETUSES EXPOSED TO ANTIBACTERIAL COMPOUNDS FACE POTENTIAL HEALTH RISKS
As the Food and Drug
Administration (FDA) mulls over whether to rein in the use of common
antibacterial compounds that are causing growing concern among environmental
health experts, scientists are reporting today that many pregnant women and
their fetuses are being exposed to these substances. They will present their
work at the 248th National Meeting & Exposition of the American Chemical
Society (ACS), the world's largest scientific society.
"We looked at the
exposure of pregnant women and their fetuses to triclosan and triclocarban, two
of the most commonly used germ-killers in soaps and other everyday
products," says Benny Pycke, Ph.D. "We found triclosan in all of the
urine samples from the pregnant women that we screened. We also detected it in
about half of the umbilical cord blood samples we took, which means it transfers
to fetuses. Triclocarban was also in many of the samples."
The problem with this,
explains Pycke, a research scientist at Arizona State University (ASU), is that
there is a growing body of evidence showing that the compounds can lead to
developmental and reproductive problems in animals and potentially in humans.
Also, some research suggests that the additives could contribute to antibiotic
resistance, a growing public health problem.
Although the human
body is efficient at flushing out triclosan and triclocarban, a person's
exposure to them can potentially be constant.
"If you cut off
the source of exposure, eventually triclosan and triclocarban would quickly be
diluted out, but the truth is that we have universal use of these chemicals,
and therefore also universal exposure," says Rolf Halden, Ph.D., the lead
investigator of the study at ASU.
The compounds are used
in more than 2,000 everyday products marketed as antimicrobial, including
toothpastes, soaps, detergents, carpets, paints, school supplies and toys, the
researchers say.
Showing what effect
antimicrobials have on people is a challenge. But Halden and Pycke's colleague
Laura Geer, Ph.D., of the State University of New York, found at least one
interesting result. Geer says the study yielded a link between women with
higher levels of another ubiquitous antimicrobial, butyl paraben, which is
commonly used in cosmetics, and shorter newborn lengths. The long-term
consequences of this are not clear, but Geer adds that, if this finding is
confirmed in larger studies, it could mean that widespread exposure to these
compounds could cause a subtle but large-scale shift in birth sizes.
State policymakers,
the FDA and industry have taken notice of the mounting evidence against
triclosan. Minnesota became the first state to pass a ban on the
antimicrobial's use in certain products, and it will take effect in January
2017. Some companies, such as Johnson & Johnson and Procter & Gamble,
have announced that they are phasing out the compound from some products. At
the federal level, the FDA and Environmental Protection Agency are reviewing
the use and effects of the compounds.
Comments
Post a Comment